In a pilot demo with 33 young children and adolescents with residual amblyopia (a problem frequently called lazy eye, where the vision in one of the eyes is minimized regardless of whether applying prescription glasses due to the brain favoring one other eye), L-DOPA/carbidopa cure for eight months